Cartalax

100% delivery

  • Done Satisfaction Guaranteed
  • Done No Hassle Refunds
  • Done Secure Payments
GUARANTEED SAFE CHECKOUT
  • Visa Card
  • MasterCard
SKU: cartalax Category:

Description

For Research Use Only. Not for Human or Veterinary Use.
Recovery20mg*10vialsHPLC ≥ 99%COA per batch

Cartalax

Specifications:
Click to preview COA & reports online View all COA
Cartalax
TL;DR

Cartalax is a research-grade peptide supplied by Peptides Duo at HPLC ≥99% purity for laboratory research use, with a Certificate of Analysis provided for every batch.

Overview

Cartalax is offered by Peptides Duo as a research-grade peptide, manufactured by solid-phase synthesis and purified by preparative HPLC. Every batch is released only after identity and purity verification.

We supply Cartalax in scalable quantities — from research samples to bulk orders — with competitive lead times, full documentation and reliable worldwide shipping.

What is Cartalax?

Cartalax is a research‑grade peptide for studies related to tissue repair and cartilage. Its identity, purity and consistency have been characterized to support reproducible laboratory research.

Why purity matters

Truncated sequences and process impurities can confound experimental results. Every batch is HPLC-tested to ≥99% and mass-confirmed, so researchers work from a well-characterized, reproducible material.

Key Highlights

  • HPLC purity ≥ 99% with a Certificate of Analysis (COA) per batch
  • Identity confirmed by LC-MS; net peptide content reported
  • Available packaging: 20mg*10vials
  • Lyophilized powder; custom packaging and labeling available
  • For laboratory research use only — not for human or veterinary use

Safety & Side Effects

Cartalax is offered by Peptides Duo as a research-grade peptide, manufactured by solid-phase synthesis and purified by preparative HPLC. Every batch is released only after identity and purity verification. When used in research, Cartalax should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.

Published cartalax side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for tissue repair and recovery readouts and any off-target effects relevant to the compound’s mechanism when designing a study.

For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.

Dosage & Protocol

There is no standardized human dosage for Cartalax; it is supplied strictly for laboratory research. Reported cartalax dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.

Research protocols typically document cartalax dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 85806-95-7, molecular formula C₁₂H₁₉N₃O₈, molecular weight 333.29 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.

Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.

Comparison

ProductMain research directionsProduct Positioning
Cartalaxcartilage, joints, connective tissueTissue/Cartilage‑related research peptides
BPC-157Tissue repair, tendons/ligaments, gastrointestinal tract, etc.Research peptides related to tissue repair
TB500tissue repair, cell migration, angiogenesis, etc.Research‑related peptides for tissue repair / cell migration

How to Order

1

Enquiry

Send product code, strength and quantity for a fast quote.

2

Quotation

Receive price, lead time and specification.

3

QC & COA

Batch tested by HPLC/LC-MS; COA issued.

4

Delivery

Discreet, tracked worldwide shipping.

Specifications

Product nameCartalax
Product codeCX20
Specification20mg*10vials
CAS number85806-95-7
Molecular formulaC₁₂H₁₉N₃O₈
Molecular weight333.29 g/mol
Purity≥99%
CategoryRecovery
AppearanceWhite lyophilized powder
Salt formFree form
Packaging20mg*10vials
DocumentationCOA, MSDS on request

Applications

ResearchLaboratoryAcademicDrug Discovery

Packaging & Shipping

Available pack sizes

20mg*10vials

Shipping

WorldwideCold ChainExpress

Storage & Handling

Store lyophilized powder sealed at −20 °C, protected from light and moisture. Allow vials to reach room temperature before opening. Once reconstituted, keep refrigerated and avoid repeated freeze–thaw cycles.